Treatment with ACE inhibitors (ACEi) and Ang II receptor blockers (ARB), which are commonly used to manage hypertension, could be beneficial in COVID-19 by potentially mitigating the harmful effects of an imbalanced RAS [42]. Here, ACE is linked to Hypertension.